Upscale AI | $5,500,000 | (May 13, 2025)
Zendo | $2,310,525 | (May 13, 2025)
theom | $20,000,000 | (May 13, 2025)
Certified by Founder
Lodge
Carmot Therapeutics, Inc.
start up
United States
- Berkeley
- 26/07/2022
- Series D
- $160,000,000
Carmot Therapeutics, Inc. is a clinical-stage company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative, patented drug discovery approach, Chemotype Evolution to explore novel frontiers of chemistry and biology. Using Chemotype Evolution, Carmot has developed a portfolio of drug candidates in metabolic disease and oncology.
- Industry Biotechnology Research
- Website https://carmot-therapeutics.us/contact-us/
- LinkedIn https://www.linkedin.com/company/carmot-therapeutics-inc/
GLASS Imaging | $20,000,000 | (May 13, 2025)
Tobin Scientific | $65,000,000 | (May 13, 2025)
Axe | $1,666,102 | (May 13, 2025)
Zapia AI | $7,250,000 | (May 13, 2025)
TensorStax | $5,000,000 | (May 13, 2025)
Alt DRX | $2,700,000 | (May 13, 2025)
Miden | $25,000,000 | (May 13, 2025)
InBrain Pharma | $2,000,943 | (May 13, 2025)
Zebu Intelligent Systems Pvt Ltd | $1,000,000 | (May 9, 2025)